QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

- This acceptance follow's Dermata's U.S. issued patent covering its Spongilla technology combination as a method to to...

 dermata-therapeutics-to-present-phase-3-star-1-xyngari-abstract-highlighting-data-in-moderate-to-severe-acne-at-eadv-congress-2025

- Abstract highlights additional primary and secondary data from Phase 3 STAR-1 clinical study of XYNGARI™ for the treatment of...

Core News & Articles

Dermata Therapeutics, Inc. (NASDAQ:DRMA)(NASDAQ:DRMAW) ("Dermata" or the "Company"), a science-driven leader in...

 maxim-group-maintains-buy-on-dermata-therapeutics-lowers-price-target-to-10

Maxim Group analyst Anthony Vendetti maintains Dermata Therapeutics (NASDAQ:DRMA) with a Buy and lowers the price target fro...

 australian-patent-office-dermata-therapeutics-patent-application-for-dmt410-program-for-hyperhidrosis-titled-compositions-for-the-treatment-of-skin-conditions-australian-patent-no-2109284621

- This is the Company's second granted patent for DMT410, using its Spongilla technology to topically deliver botulinum tox...

 maxim-group-maintains-buy-on-dermata-therapeutics-lowers-price-target-to-3

Maxim Group analyst Anthony Vendetti maintains Dermata Therapeutics (NASDAQ:DRMA) with a Buy and lowers the price target fro...

Core News & Articles

- Dermata previously announced XYNGARI(TM) produced highly statistically significant topline data for all primary endpoints at ...

 us-stocks-likely-to-open-lower-analysts-warn-prolonged-uncertainty-could-hurt-both-us-and-global-risk-assets

U.S. stock futures fell on Friday after two consecutive days of decline on Wednesday and Thursday. Futures of benchmark indices...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION